RECURRENT OR METASTATIC SOLID TUMORS
Clinical trials for RECURRENT OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for RECURRENT OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug gets a needle upgrade: shot form tested in advanced tumors
Disease control Recruiting nowThis early-stage trial tests a new way to give the cancer drug trastuzumab deruxtecan (T-DXd) as a shot under the skin instead of through an IV. It aims to see if the shot is safe and works well in people with metastatic solid tumors that have spread. About 76 adults with advance…
Matched conditions: RECURRENT OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug targets 13 hard-to-treat cancers in major trial
Disease control Recruiting nowThis study tests an experimental drug called ifinatamab deruxtecan (I-DXd) in people whose cancer has come back or spread. It includes 13 different cancer types, such as endometrial, head and neck, pancreatic, and breast cancers. The goal is to see if the drug can shrink tumors a…
Matched conditions: RECURRENT OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 11, 2026 20:39 UTC